Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling. This year’s Scientific Content Partners are the Cell & Gene Therapy Catapult, the Royal Society of Chemistry, SBi2 and SLAS, all of whom are providing science tracks prepared by their community members. And in the middle of all this science there is the exhibition hall, which is a great opportunity to meet over two hundred drug discovery suppliers and to learn about all the latest products and services you can use in your research.
Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic themes such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high content imaging, target identification and disease modelling.
This year’s Scientific Content Partners are the Cell & Gene Therapy Catapult, the Royal Society of Chemistry, SBi2 and SLAS, all of whom are providing science tracks prepared by their community members. And in the middle of all this science there is the exhibition hall, which is a great opportunity to meet over two hundred drug discovery suppliers and to learn about all the latest products and services you can use in your research. Whether you’re involved in early drug discovery research or translating your promising therapy to the clinic, you’ll be sure to discover something that can help you at this year’s event.
ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a prayer room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events.